Delivery Order SPE2DB20D2014-SPE2DB25FB62F

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $140,206.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medication used for various medical conditions. The contract has an ultimate completion date of September 26, 2023 and was awarded on September 25, 2023. This contract is a part of a larger $999,999,999 Indefinite Delivery Contract...
This is a $17,849.04 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a completion date of May 29, 2025. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This is a $20,270.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,284.17, is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication used to treat various autoimmune conditions. The contract has an ultimate completion date of March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a $5,572.33 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has a completion date of May 21, 2024. While the original solicitation is not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $1,373.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medication used to treat various medical conditions. The contract has a completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $8,995.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medication used to treat various medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a $4,531.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication used to treat various autoimmune conditions. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. This contract is not associated with a set-aside designation....
This is a $2,265.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the procurement of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication, with a performance period ending on January 15, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a $53,822.10 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication used to treat various autoimmune conditions. The contract has an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB62F
    Delivery Order

This is a $2,265.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition.

Generated 7/11/25, 9:45 AM